Back to search

Substance-P-Mediated Intestinal Inflammation: Inhibitory Effects of CP 96,345 and SMS 201-995

Data up to Jan 2025

Published1994
Citations53
References30

Total Citations Per Year

Abstract

References (30)

The Enteric Nervous System

2016 • 1,113 citations

Effect of Neuropeptides on Production of Inflammatory Cytokines by Human Monocytes

1988 • 929 citations

A Potent Nonpeptide Antagonist of the Substance P (NK 1 ) Receptor

1991 • 875 citations

Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen.

1986 • 579 citations

Intraneuronal Substance P Contributes to the Severity of Experimental Arthritis

1984 • 521 citations

Substance P: binding properties and studies on cellular responses in guinea pig macrophages.

1986 • 262 citations

Substance P receptor-mediated chemotaxis of human monocytes

1985 • 222 citations

Distribution of substance P receptors on murine spleen and Peyer's patch T and B cells.

1987 • 174 citations

Substance p and arthritis: analysis of plasma and synovial fluid levels

1990 • 171 citations

Neuropeptide Regulation of Mucosal Immunity

1987 • 170 citations

Substance P enhances IL-2 expression in activated human T cells.

1992 • 145 citations

Increased levels of substance P in the myenteric plexus of Trichinella-infected rats

1992 • 135 citations

Stimulation of monocyte chemotaxis by human growth hormone and its deactivation by somatostatin

1993 • 108 citations

Substance P and the Inflammatory and Immune Response

1991 • 104 citations

Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease.

1992 • 102 citations

Innervation of mucosal immune cells in the gastrointestinal tract.

1992 • 93 citations

Airway neuropeptides and asthma

1987 • 91 citations

Substance P and Calcitonin Gene‐Related Peptide (CGRP) in Gastrointestinal Inflammationa

1992 • 90 citations

Substance P acts directly upon cloned B lymphoma cells to enhance IgA and IgM production.

1991 • 89 citations

Neuropeptides and inflammation. A somatostatin analog as a selective antagonist of neutrophil activation by substance P

1992 • 70 citations

Selective modulation of the natural killer activity of murine intestinal intraepithelial leucocytes by the neuropeptide substance P.

1990 • 48 citations

Monocytes express a non-neurokinin substance P receptor that is functionally coupled to MAP kinase.

1994 • 45 citations

Inhibition of murine intestinal inflammation by anti-substance P antibody.

1993 • 42 citations

Mast cells in the regulation of intestinal electrolyte transport

1986 • 33 citations

Are lymphocytes a target for substance P modulation in arthritis?

1992 • 32 citations

Immunomodulatory activities of the somatostatin analogue BIM 23014c: effects on murine lymphocyte proliferation and natural killer activity

1991 • 27 citations

SENSORY NEUROPEPTIDES AND RHEUMATIC DISEASES

1993 • 20 citations

VIP Restores Natural Killer Cell Activity Depressed by Hepatitis B Surface Antigen

1992 • 10 citations

Role of NK-1 receptor in central cardiovascular regulation in rats: studies on a novel non-peptide antagonist, CP-96,345, of substance P NK-1 receptor

1993 • 5 citations

Antiinflammatory and analgesic activity of CP-96,345: on orally active non-peptide substance P receptor antagonist

1993 • 4 citations

Cited By (0)

Loading...
Substance-P-Mediated Intestinal Inflammation: Inhibitory Effects of CP 96,345 and SMS… (1994) – NeuroImmunoModulation | Metascience Observatory Explorer